Peter Caravan

Citée par

	Toutes	Depuis 2019
Citations	25275	9874
indice h	67	46
indice i10	185	144

2100

1050

525

1575

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024119 149 215 227 305 428 491 589 607 749 865 995 1124 1362 1257 1392 1281 1388 1531 1568 1750 2080 1983 1754 736

Accès public

Tout afficher

144 articles

5 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Eric GaleAssistant Professor of Radiology, Harvard Medical SchoolAdresse e-mail validée de nmr.mgh.harvard.edu
Bryan C FuchsAssistant Professor of Surgery, Harvard Medical SchoolAdresse e-mail validée de mgh.harvard.edu
Kenneth K> TanabeProfessor of Surgery, Harvard Medical School, Massachusetts General HospitalAdresse e-mail validée de partners.org
Christian T. FarrarMassachusetts General HospitalAdresse e-mail validée de nmr.mgh.harvard.edu
Mozhdeh SojoodiInstructor in SurgeryAdresse e-mail validée de mgh.harvard.edu
Francesco BlasiBracco Imaging spaAdresse e-mail validée de bracco.com
Eszter BorosUniversity of Wisconsin-MadisonAdresse e-mail validée de wisc.edu
Derek ErstadAssistant Professor of Surgery, Division of Surgical Oncology, Baylor College of MedicineAdresse e-mail validée de bcm.edu
Chris OrvigProfessor of Chemistry and Pharmaceutical SciencesAdresse e-mail validée de chem.ubc.ca
Dean SherryUniversity of Texas Southwestern Medical CenterAdresse e-mail validée de utsouthwestern.edu
Andrei AstashkinDepartment of Chemistry and Biochemistry, University of ArizonaAdresse e-mail validée de u.arizona.edu
Stephan G. ZechAmgenAdresse e-mail validée de amgen.com
Eva Jakab TothCNRSAdresse e-mail validée de cnrs-orleans.fr
Jeff BulteProfessor of Radiology, Johns Hopkins University School of MedicineAdresse e-mail validée de mri.jhu.edu
Anthony D SchmittArima GenomicsAdresse e-mail validée de arimagenomics.com
Alex NivorozhkinNeo-Advent Technologies LLCAdresse e-mail validée de neo-adventtec.com
Silvio AimeUniversity of TorinoAdresse e-mail validée de unito.it
Rene M Botnar, PhDProfessor of Cardiovascular Imaging, King's College LondonAdresse e-mail validée de kcl.ac.uk
Claudio LuchinatCERM, CIRMMP and Department of Chemistry University of FlorenceAdresse e-mail validée de cerm.unifi.it

Suivre

Peter Caravan

Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging (i3), MGH, Harvard

Adresse e-mail validée de nmr.mgh.harvard.edu

Chemistry PET MRI Thrombosis Fibrosis


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications P Caravan, JJ Ellison, TJ McMurry, RB Lauffer Chem. Rev 99, 2293-2352, 1999	5499	1999
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents P Caravan Chemical Society Reviews 35 (6), 512-523, 2006	1706	2006
The chemistry of contrast agents in medical magnetic resonance imaging AS Merbach, L Helm, É Tóth John Wiley & Sons, 2013	1696	2013
Chemistry of MRI contrast agents: current challenges and new frontiers J Wahsner, EM Gale, A Rodríguez-Rodríguez, P Caravan Chemical reviews 119 (2), 957-1057, 2018	1198	2018
Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition S Aime, P Caravan Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009	625	2009
Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium‐ and manganese‐based T₁ contrast agents P Caravan, CT Farrar, L Frullano, R Uppal Contrast media & molecular imaging 4 (2), 89-100, 2009	608	2009
The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates P Caravan, NJ Cloutier, MT Greenfield, SA McDermid, SU Dunham, ... Journal of the American Chemical Society 124 (12), 3152-3162, 2002	540	2002
Primer on gadolinium chemistry AD Sherry, P Caravan, RE Lenkinski Journal of magnetic resonance imaging: an official journal of the …, 2009	473	2009
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action P Caravan Accounts of chemical research 42 (7), 851-862, 2009	447	2009
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ... Hepatology 59 (4), 1577-1590, 2014	349	2014
Reaction chemistry of BMOV, bis (maltolato) oxovanadium (IV), a potent insulin mimetic agent C Orvig, P Caravan, L Gelmini, N Glover, FG Herring, H Li, JH McNeill, ... Journal of the American Chemical Society 117 (51), 12759-12770, 1995	335	1995
A manganese alternative to gadolinium for MRI contrast EM Gale, IP Atanasova, F Blasi, I Ay, P Caravan Journal of the American Chemical Society 137 (49), 15548-15557, 2015	319	2015
Collagen-targeted MRI contrast agent for molecular imaging of fibrosis P Caravan, B Das, S Dumas, FH Epstein, PA Helm, V Jacques, S Koerner, ... ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH- 46 (43), 8171, 2007	279	2007
Clinical magnetic resonance imaging RR Edelman, JR Hesselink (No Title), 2006	259	2006
EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus K Overoye-Chan, S Koerner, RJ Looby, AF Kolodziej, SG Zech, Q Deng, ... Journal of the American Chemical Society 130 (18), 6025-6039, 2008	253	2008
Gut microbiota is critical for the induction of chemotherapy-induced pain S Shen, G Lim, Z You, W Ding, P Huang, C Ran, J Doheny, P Caravan, ... Nature neuroscience 20 (9), 1213-1216, 2017	226	2017
Contrast agents for MRI: 30+ years and where are we going? VC Pierre, MJ Allen, P Caravan JBIC Journal of Biological Inorganic Chemistry 19, 127-131, 2014	201	2014
Postinfarction Myocardial Scarring in Mice: Molecular MR Imaging with Use of a Collagen-targeting Contrast Agent¹ PA Helm, P Caravan, BA French, V Jacques, L Shen, Y Xu, RJ Beyers, ... Radiology 247 (3), 788-796, 2008	193	2008
Enzyme-Activated Gd³⁺ Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor-Induced Magnetization Enhancement. AL Nivorozhkin, AF Kolodziej, P Caravan, MT Greenfield, RB Lauffer, ... Angewandte Chemie (International ed. in English) 40 (15), 2903-2906, 2001	185	2001
Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility J Vymazal, E Spuentrup, G Cardenas-Molina, AJ Wiethoff, MG Hartmann, ... Investigative radiology 44 (11), 697-704, 2009	184	2009

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs